Figure 2.

Peptides from (a) CPHD and (b) its cationic peptide fraction inhibits LPS-induced inflammation in RAW 264.7 Cells. Different lowercase letters indicate significant differences between treatments (p < 0.05). Samples were analyzed in quadruplicate (n = 4). Cells were stimulated for 6 h with 500 ng of lipopolysaccharide (LPS) or pre-treated with CPHD (a), cationic fractions, or PBS (NTC = non-treated control). The data are expressed as the Renilla luciferase activity in relative light units (RLU). Data represent the mean ± SD of quadruplicate samples, representative of four independent experiments.